Tobaiqy M - Search Results

1

Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database.

Tobaiqy M, Elkout H. Tobaiqy M, et al. Int J Clin Pharm. 2024 Apr;46(2):488-495. doi: 10.1007/s11096-023-01694-7. Epub 2024 Jan 24. Int J Clin Pharm. 2024. PMID: 38265519 Free PMC article.

2

A pilot study to evaluate a community pharmacy-based monitoring system to identify adverse drug reactions associated with paediatric medicines use.

Tobaiqy M, Stewart D, Helms PJ, Bond C, Lee AJ, Bateman N, McCaig D, McLay J. Tobaiqy M, et al. Eur J Clin Pharmacol. 2010 Jun;66(6):627-32. doi: 10.1007/s00228-010-0790-9. Epub 2010 Mar 2. Eur J Clin Pharmacol. 2010. PMID: 20195588 Free article.

3

Views of parents and pharmacists following participation in a paediatric pharmacovigilance study.

Tobaiqy M, Stewart D, Helms PJ, Bond CM, Lee AJ, McLay J. Tobaiqy M, et al. Pharm World Sci. 2010 Jun;32(3):334-8. doi: 10.1007/s11096-010-9374-0. Epub 2010 Feb 25. Pharm World Sci. 2010. PMID: 20182797

4

Parental reporting of adverse drug reactions associated with attention-deficit hyperactivity disorder (ADHD) medications in children attending specialist paediatric clinics in the UK.

Tobaiqy M, Stewart D, Helms PJ, Williams J, Crum J, Steer C, McLay J. Tobaiqy M, et al. Drug Saf. 2011 Mar 1;34(3):211-9. doi: 10.2165/11586050-000000000-00000. Drug Saf. 2011. PMID: 21332245

5

Foundation year 1 doctors and clinical pharmacology and therapeutics teaching. A retrospective view in light of experience.

Tobaiqy M, McLay J, Ross S. Tobaiqy M, et al. Br J Clin Pharmacol. 2007 Sep;64(3):363-72. doi: 10.1111/j.1365-2125.2007.02925.x. Epub 2007 May 15. Br J Clin Pharmacol. 2007. PMID: 17506779 Free PMC article.

6

Exploring health professionals' experiences of medication errors in Saudi Arabia.

Tobaiqy M, Stewart D. Tobaiqy M, et al. Int J Clin Pharm. 2013 Aug;35(4):542-5. doi: 10.1007/s11096-013-9781-0. Epub 2013 May 7. Int J Clin Pharm. 2013. PMID: 23649894

7

General public's perspectives of issues relating to misuse of medicines: a cross-sectional survey in Jeddah, Saudi Arabia.

Tobaiqy M, Radwi M, Alhasan AH, Basaeed LF, Stewart D. Tobaiqy M, et al. Int J Clin Pharm. 2019 Oct;41(5):1148-1151. doi: 10.1007/s11096-019-00893-5. Epub 2019 Oct 1. Int J Clin Pharm. 2019. PMID: 31576480

8

Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database.

Tobaiqy M, Elkout H, MacLure K. Tobaiqy M, et al. Vaccines (Basel). 2021 Apr 16;9(4):393. doi: 10.3390/vaccines9040393. Vaccines (Basel). 2021. PMID: 33923530 Free PMC article.

9

Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database.

Tobaiqy M, MacLure K, Elkout H, Stewart D. Tobaiqy M, et al. Vaccines (Basel). 2021 Nov 15;9(11):1326. doi: 10.3390/vaccines9111326. Vaccines (Basel). 2021. PMID: 34835256 Free PMC article.

10

The prevalence of hepatic and thyroid toxicity associated with imatinib treatment of chronic myeloid leukaemia: a systematic review.

Tobaiqy M, Helmi N, MacLure K, Saade S. Tobaiqy M, et al. Int J Clin Pharm. 2024 Apr;46(2):368-381. doi: 10.1007/s11096-023-01671-0. Epub 2023 Dec 26. Int J Clin Pharm. 2024. PMID: 38147280

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters